Role of Marma Therapy and Agnikarma in the pain management of Sciatica

A COMPARATIVE CLINICO-ANATOMICAL STUDY OF MARMA THERAPY AND AGNIKARMA IN THE PAIN MANAGEMENT OF GRIDHRASI (SCIATICA) - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/069263

Enrollment

Registered

2024-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica Health Condition 2: M511- Thoracic, thoracolumbar and lumbosacral intervertebral disc disorders with radiculopathy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Gridhrasi (Sciatica) Patient having classical signs and symptoms of Gridhrasi Patients belonging to the age group of 16 - 70 years of either sex Positive SLR test • Positive Lasegue’s sign

Exclusion criteria

Exclusion criteria: Uncontrolled Diabetes Mellitus T.B. of Spine & Hip joint Malignancy of Spine or other organs History with Spine fracture (trauma) Pregnancy Age below 16 and above 70 years of either sex

Design outcomes

Primary

Measure	Time frame
Marma Therapy and Aganikarma will be effective to ameliorate pain and other symptom of Gridhrasi.Timepoint: 30 days	—

Secondary

Measure	Time frame
Marma Therapy will be provide a safe & effective treatment Aganikarma will be helpful to reduce symptom of Gridhrasi Timepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Rakesh Kumar Sharma

Post Graduate Institute of Ayurveda

Sadhanasharma4161@gmail.com9571054161

Outcome results